[A New Era of Cancer Prevention from Dentistry] Saliva Cancer Risk Testing Bridges Medical Care: Promoting Early Detection via Oral Care to Enhance Health Span

Key facts

  • [A New Era of Cancer Prevention from Dentistry] Saliva Cancer Risk Testing Bridges Medical Care: Promoting Early Detection via Oral Care to Enhance Health Span
  • Salivatech presented on the systemic cancer risk assessment and medical referral potential of their "SalivaChecker®" test at the 23rd Annual Meeting of the Japanese Society of Oral Care. By integrating saliva testing into routine oral care, the company aims to promote early cancer detection and enhance health span. The seminar achieved an 85.2% satisfaction rate, highlighting significant professional interest in interdisciplinary cooperation.
  • Source: PR Times
  • Date: May 27, 2026

Direct answer

Salivatech presented on the systemic cancer risk assessment and medical referral potential of their "SalivaChecker®" test at the 23rd Annual Meeting of the Japanese Society of Oral Care. By integrating saliva testing into routine oral care, the company aims to promote early cancer detection and enhance health span. The seminar achieved an 85.2% satisfaction rate, highlighting significant professional interest in interdisciplinary cooperation.

Citation
[A New Era of Cancer Prevention from Dentistry] Saliva Cancer Risk Testing Bridges Medical Care: Promoting Early Detection via Oral Care to Enhance Health Span (May 27, 2026), PR Times
Source
PR Times
Date
May 27, 2026
Salivatech presented on the systemic cancer risk assessment and medical referral potential of their "SalivaChecker®" test at the 23rd Annual Meeting of the Japanese Society of Oral Care. By integrating saliva testing into routine oral care, the company aims to promote early cancer detection and enhance health span. The seminar achieved an 85.2% satisfaction rate, highlighting significant professional interest in interdisciplinary cooperation.
イベントNQ 82/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 27, 2026 at 01:00
  • 🔍 Collected: May 26, 2026 at 16:31
  • 🤖 AI Analyzed: May 26, 2026 at 16:46 (15 min after Collected)
Salivatech (Headquarters: Tsuruoka, Yamagata; CEO: Makoto Sunamura), provider of the saliva-based cancer risk test "SalivaChecker®," announced that Masahiro Sugimoto, Director of Salivatech (and Professor at Keio University Graduate School of Media and Governance), and Remi Onuma, Medical Institutional Sales, presented at a luncheon seminar during the 23rd Annual Meeting of the Japanese Society of Oral Care.

The seminar highlighted the utility of saliva testing in the dental and oral care field, systemic cancer risk assessment through oral care, and bridging patients to appropriate medical treatment to increase health span, drawing significant interest from medical professionals.

Seminar Overview
Seminar Title: Luncheon Seminar "Unlocking Systemic Signals through Oral Care"
Speaker 1: "Perspectives Connecting Oral Care and Systemic Management" - Masahiro Sugimoto
Speaker 2: "A New Option for Early Cancer Detection: Saliva Cancer Risk Test 'SalivaChecker'" - Remi Onuma

From Oral Care to Systemic Health: Salivatech's Story of Enhancing Health Span
Recent studies show that poor oral care is not only a cause of tooth decay and periodontal disease but can also trigger serious systemic diseases. Salivatech believes that by incorporating saliva testing into routine oral care at dental clinics, patients can be connected to appropriate medical treatment, contributing to increased health span.

Covering 6 Types of Cancer with One Drop of Saliva
SalivaChecker® can evaluate the risk of 6 types of cancer simultaneously: oral cancer, pancreatic cancer, lung cancer, stomach cancer, colorectal cancer, and breast cancer (women only).

Bridging from 'Notice' to 'Appropriate Medical Care'
By testing at dental clinics, which are visited regularly, potential cancer risks can be visualized even in the asymptomatic stage. The company constructs a mechanism to smoothly bridge patients with high risk scores to appropriate medical institutions.

Seminar Survey: Over 85% Satisfied
- Participant satisfaction was 85.2%.
- Diverse participants: Dentists (18.5%), Dental Hygienists (30.9%), Nurses (30.9%).
- Facility types: Hospitals (61.3%), Dental Clinics (10.0%).
- Practicality: 72.7% found the test 'useful' for clinical work.

FAQ

What can the SalivaChecker® tell you?

A single saliva sample can simultaneously assess the risk of six types of cancer: oral, pancreatic, lung, stomach, colorectal, and breast cancer (for women only).

What are the benefits of getting cancer risk tests at a dental clinic?

Regular visits to a dental clinic for testing can help visualize potential cancer risks even before symptoms appear, and provide a referral system for high-risk individuals to specialized medical facilities.

How satisfied were the seminar participants?

The overall satisfaction rate among participants was 85.2% (very satisfied and satisfied combined).

Who were the main speakers at the seminar?

The main speakers were Masahiro Sugimoto, a professor at Keio University and a board member of Salivatec, and Reimi Konuma, a medical institution sales representative at the company.

What is Salivatec's vision for promoting healthy longevity?

Salivatec aims to integrate saliva testing into routine oral care to manage overall cancer risk, enabling early disease detection and contributing to a society where residents can live longer and healthier lives.